<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2307-3349</journal-id>
<journal-title><![CDATA[Revista de salud publica del Paraguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. salud publica Parag.]]></abbrev-journal-title>
<issn>2307-3349</issn>
<publisher>
<publisher-name><![CDATA[INSTITUTO NACIONAL DE SALUD - MSP Y BS]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2307-33492021000100112</article-id>
<article-id pub-id-type="doi">10.18004/rspp.2021.junio.112</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome de Guillain Barré asociado a la infección por el SARS-CoV-2, en paciente con diagnóstico diferencial por dengue]]></article-title>
<article-title xml:lang="en"><![CDATA[Guillain Barré syndrome associated with SARS-CoV-2 infection in a patient with a differential diagnosis of dengue]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montiel-Jarolín]]></surname>
<given-names><![CDATA[Dora Elizabeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dure]]></surname>
<given-names><![CDATA[Cesar Damián Riveros]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aveiro]]></surname>
<given-names><![CDATA[Alba]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Estela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jarolin]]></surname>
<given-names><![CDATA[Magali Sylvia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Taboada]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Hospital Nacional de Itauguá Departamento de Medicina Interna]]></institution>
<addr-line><![CDATA[Itaugúa ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>11</volume>
<numero>1</numero>
<fpage>112</fpage>
<lpage>116</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2307-33492021000100112&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2307-33492021000100112&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2307-33492021000100112&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  El síndrome de Guillain- Barré ha sido asociado a la infección por el virus SARS-CoV-2 desde los inicios de la pandemia.  Caso clínico:  Varón de 56 años de edad sin comorbilidad, ni hábitos tóxicos, consulta por cuadro de 4 días de evolución con parestesias a nivel de manos y pies en simultáneo, debilidad de miembros inferiores, sin otros síntomas. El paciente 22 días antes, presentó tos y disnea, de 3 días de evolución, el hisopado nasofaríngeo para SARS-CoV-2 fue positivo, con tratamiento ambulatorio. Refirió dengue en diciembre 2019. Examen físico: Presión arterial 140/80 mmHg, frecuencia cardiaca 114 por minuto, temperatura 36 grados, frecuencia respiratoria 20 por minuto. Examen neurológico: paciente lúcido, disminución de la fuerza muscular de miembros inferiores 4/5, reflejos osteotendinosos abolidos en cuatro miembros, sin nivel sensitivo ni compromiso esfinteriano, signo de Babinski negativo, signos meníngeos ausentes. Resto del examen físico sin datos de valor. Pruebas laboratoriales: glóbulos blancos 11,5 x 109/L, neutrófilos: 74%, linfocitos: 18%. Eritrosedimentación 14 mm, Serología Elisa: HIV: negativo, serología IGM negativo: herpes simple, citomegalovirus, dengue antígeno NS1: negativo; dengue serología IgG e IgM: positivo (noviembre 2020, test inmunocromatografico, SD, korea), (SARS-CoV-2 IgG/IgM positivo, zika y chikungunya negativo). Anticuerpo anti nuclear (ANA): 1/80, anti desoxirribonucleasa (anti DNA): negativo, serología negativo (anti proteinasa 3/mieloperoxidasa). Líquido cefalorraquídeo:(LCR): (glucorraquia: 63 mg/dL proteína: 88 mg/dL leucocitos: 2 células/&#956;l). La PCR en el LCR para el virus SARS-CoV-2 no fue realizada. Electromiografía: polirradiculoneuropatia desmielinizante. Tac de tórax: patrón en vidrio esmerilado parcheado, bilateral. Recibió inmunoglobulina intravenosa con recuperación completa de la fuerza muscular.  Discusión:  El SGB se presentó en el día 22 de la enfermedad por COVID-19, hay una relación temporal, responde a un modelo post infeccioso y la patogenia sería de naturaleza autoinmune]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Guillain-Barré syndrome has been associated with infection by the SARS-CoV-2 virus since the beginning of the pandemic.  Clinical case:  56-year-old man without comorbidity or toxic habits, consultation for a 4-day history of paresthesia in the hands and feet simultaneously, lower limb weakness, without other symptoms. The patient 22 days before, presented cough and dyspnea, 3 days of evolution, the nasopharyngeal swab for SARS-CoV-2 was positive, with outpatient treatment. He was referred to dengue in december 2019. Physical examination: Blood pressure 140/80 mmHg, heart rate 114 per minute, temperature 36 degrees, respiratory rate 20 per minute. Neurological examination: lucid patient, decreased muscular strength of the lower limbs 4/5, absent osteotendinous reflexes in four limbs, without sensory level or sphincter involvement, negative Babinski sign, absent meningeal signs. Rest of the physical examination without valuable data. Laboratory tests: white blood cells 11.5 x 10 9 / L, neutrophils: 74%, lymphocytes: 18%. Erythrosedimentation 14 mm, glycemia 99 mg / dL urea: 19 mg / dl, creatinine: 0.7 mg / dL, arterial gas: pH: 7.39, pco2: 27, pO2: 76, EB: - 7.6, HCO3 16 SO2: 96 , D-dimer 489 ng / ml. Elisa serology: HIV: negative, IGM serology negative: herpes simplex, cytomegalovirus, dengue antigen NS1: negative; dengue IgG and IgM serology: positive (November 2020, immunochromatographic test, SD, Korea), (SARS-CoV-2 IgG / IgM positive, Zika and chikungunya negative). Antinuclear antibody (ANA): 1/80, anti deoxyribonuclease (anti DNA): negative, serology negative (anti proteinase 3 / myeloperoxidase, extractable antigen from the nucleus) Cerebrospinal fluid: (CSF): (glycorrhachia) : 63 mg / dL protein: 88 mg / dL leukocytes: 2 cells / &#956;l). PCR in CSF for SARS-CoV-2 virus was not performed. Electromyography: Findings suggestive of demyelinating polyradiculoneuropathy. Chest CT scan: pattern in bilateral patched ground glass He was treated with intravenous immunoglobulin with complete recovery of muscle strength.  Discussion:  GBS appeared on day 22 of the COVID-19 disease, there is a temporal relationship, it responds to post-infectious model and the pathogenesis would be autoimmune in nature]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[síndrome de Guillain-Barré: SARS-CoV-2]]></kwd>
<kwd lng="es"><![CDATA[dengue]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Guillain-Barré syndrome]]></kwd>
<kwd lng="en"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="en"><![CDATA[dengue]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas de 138 pacientes hospitalizados con neumonía infectada por el nuevo coronavirus de 2019 en Wuhan, China.]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2020</year>
<volume>323</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1061-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública y Bienestar Social, Dirección de Vigilancia de Salud</collab>
<source><![CDATA[COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Manifestaciones neurológicas de pacientes hospitalizados con COVID-19 en Wuhan, China: un estudio de serie de casos retrospectivo.]]></source>
<year>2020</year>
<publisher-name><![CDATA[MedRxiv]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meppiel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Peiffer-Smadja]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Maury]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestations neurologiques associées à l&#8217;infection SARS-CoV-2 : le registre français NeuroCOVID.]]></article-title>
<source><![CDATA[Med Mal Infect.]]></source>
<year>2020</year>
<volume>50</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>S20-1</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rathore]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones neurológicas y complicaciones deCOVID-19 : revisión de la literatura.]]></article-title>
<source><![CDATA[J. Clin. Neurosci.]]></source>
<year>2020</year>
<volume>77</volume>
<page-range>8-12</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toscano]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Palmerini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ravaglia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré Syndrome Associated with SARS-CoV-2.]]></article-title>
<source><![CDATA[N Eng J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>26</numero>
<issue>26</issue>
<page-range>2574-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sedaghat]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Karimi]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Guillain Barre asociado con la infección porCOVID-19 : Reporte de un caso.]]></article-title>
<source><![CDATA[J. Clin. Neurosci.]]></source>
<year>2020</year>
<volume>76</volume>
<page-range>233-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Virani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rabold]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hanson]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré Syndrome associated with SARS-CoV-2 infection.]]></article-title>
<source><![CDATA[ID Cases.]]></source>
<year>2020</year>
<volume>20</volume>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnaud]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Budowski]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ng Wing Tin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Degos]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post SARS-CoV-2 Síndrome de Guillain-Barré.]]></article-title>
<source><![CDATA[Clin Neurophysiol.]]></source>
<year>2020</year>
<volume>131</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1652-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Padroni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mastrangelo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Asioli]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome followingCOVID-19 : new infection, old complication?]]></article-title>
<source><![CDATA[J Neurol.]]></source>
<year>2020</year>
<volume>267</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1877-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Guillain-Barré asociado con la infección por SARS-CoV-2: ¿causalidad o coincidencia?]]></article-title>
<source><![CDATA[The Lancet Neurol]]></source>
<year>2020</year>
<volume>19</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>383-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yachou]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[El Idrissi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Belapasov]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ait Benali]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.]]></article-title>
<source><![CDATA[Neurol Sci.]]></source>
<year>2020</year>
<volume>41</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2657-69</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ehrenfeld]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tincani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Andreoli]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covid-19 y autoinmunidad.]]></article-title>
<source><![CDATA[Autoimmun Rev]]></source>
<year>2020</year>
<volume>19</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>102597</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuropatías, radiculopatías y plexopatías.]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2019</year>
<volume>12</volume>
<numero>75</numero>
<issue>75</issue>
<page-range>4423-36</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Paraguay, Ministerio de Salud Pública y Bienestar Social, DireccióndeVigilanciadeSalud</collab>
<source><![CDATA[Arbovirosis]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brasil]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sequeira]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome associated with Zika virus infection.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2016</year>
<volume>387</volume>
<numero>10026</numero>
<issue>10026</issue>
<page-range>1482</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[MES]]></given-names>
</name>
<name>
<surname><![CDATA[Bachur]]></surname>
<given-names><![CDATA[TPR]]></given-names>
</name>
<name>
<surname><![CDATA[Aragão]]></surname>
<given-names><![CDATA[GF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barre syndrome and its correlation with dengue, Zika and chikungunya viruses infection based on a literature review of reported cases in Brazil.]]></article-title>
<source><![CDATA[Acta Trop.]]></source>
<year>2019</year>
<volume>197</volume>
<page-range>105064</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puccioni Sohler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Orsini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dengue: a new challenge for neurology.]]></article-title>
<source><![CDATA[Neurol Int.]]></source>
<year>2012</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brasil]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sequeira]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré syndrome associated with Zika virus infection.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2016</year>
<volume>387</volume>
<numero>10026</numero>
<issue>10026</issue>
<page-range>1482</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina González]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chiquete]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Guillain-Barré asociado a dengue: reporte de caso.]]></article-title>
<source><![CDATA[Rev Mex Neuroci.]]></source>
<year>2011</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>159-61</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suryapranata]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Chong]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Guillain-Barré Syndrome in Aruba.]]></article-title>
<source><![CDATA[Am J Trop Med Hyg.]]></source>
<year>2016</year>
<volume>94</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1380-4</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Billot]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guyon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early Guillain-Barre Syndrome associated with acute dengue fever.]]></article-title>
<source><![CDATA[J Clin Virol.]]></source>
<year>2016</year>
<volume>77</volume>
<page-range>29-31</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chien]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[ZH]]></given-names>
</name>
<name>
<surname><![CDATA[Tseng]]></surname>
<given-names><![CDATA[FC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Persistencia prolongada de IgM contra el virus del dengue detectada por ensayos comerciales de uso común.]]></article-title>
<source><![CDATA[BMC Infect Dis.]]></source>
<year>2018</year>
<volume>156</volume>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Lam]]></surname>
<given-names><![CDATA[LTM]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Chua]]></surname>
<given-names><![CDATA[YX]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[AYN]]></given-names>
</name>
<name>
<surname><![CDATA[Phang]]></surname>
<given-names><![CDATA[KF]]></given-names>
</name>
<name>
<surname><![CDATA[Kew]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Teng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ngai]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Foo]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Pada]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Tambyah]]></surname>
<given-names><![CDATA[PA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covert COVID-19 and false-positive dengue serology in Singapore.]]></article-title>
<source><![CDATA[Lancet Infect Dis.]]></source>
<year>2020</year>
<volume>20</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>536</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
